Search Results - "Kopp, V M"

Perspectives in allergen immunotherapy: 2017 and beyond by Pfaar, O., Bonini, S., Cardona, V., Demoly, P., Jakob, T., Jutel, M., Kleine‐Tebbe, J., Klimek, L., Klysner, S., Kopp, M. V., Kuna, P., Larché, M., Muraro, A., Schmidt‐Weber, C. B., Shamji, M. H., Simonsen, K., Somoza, C., Valovirta, E., Zieglmayer, P., Zuberbier, T., Wahn, U.

“…The Future of the Allergists and Specific Immunotherapy (FASIT) workshop provides a regular platform for global experts from academia, allergy clinics,…”
Get full text

Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma by Kopp, M. V., Hamelmann, E., Zielen, S., Kamin, W., Bergmann, K.-C., Sieder, C., Stenglein, S., Seyfried, S., Wahn, U.

“…Summary Background The treatment of allergic asthma by specific immunotherapy (SIT) is hampered by potential side‐effects. Objective The aim of this study was…”
Get full text

Perspectives on allergen-specific immunotherapy in childhood: An EAACI position statement by Calderon, M. A., Gerth van Wijk, R., Eichler, I., Matricardi, P. M., Varga, E. M., Kopp, M. V., Eng, P., Niggemann, B., Nieto, A., Valovirta, E., Eigenmann, P. A., Pajno, G., Bufe, A., Halken, S., Beyer, K., Wahn, U.

“…To cite this article: Calderon MA, Gerth van Wijk R, Eichler I, Matricardi PM, Varga EM, Kopp MV, Eng P, Niggemann B, Nieto A, Valovirta E, Eigenmann PA, Pajno…”
Get full text

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer by Cohn, A.L., Tabernero, J., Maurel, J., Nowara, E., Sastre, J., Chuah, B.Y.S., Kopp, M.V., Sakaeva, D.D., Mitchell, E.P., Dubey, S., Suzuki, S., Hei, Y.-J., Galimi, F., McCaffery, I., Pan, Y., Loberg, R., Cottrell, S., Choo, S.-P.

“…Targeted agents presently available for mutant KRAS metastatic colorectal cancer (mCRC) are bevacizumab and aflibercept. We evaluated the efficacy and safety…”
Get full text

Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-γ release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates by Kopp, M. V., Goldstein, M., Dietschek, A., Sofke, J., Heinzmann, A., Urbanek, R.

“…Summary Background The value of probiotics for primary prevention is controversial. Moreover, only little is known about the underlying immunological…”
Get full text

A prospective, randomized, double‐blind, placebo‐controlled multi‐centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen by Rolinck‐Werninghaus, C., Wolf, H., Liebke, C., Baars, J. C., Lange, J., Kopp, M. V., Hammermann, J., Leupold, W., Bartels, P., Gruebl, A., Bauer, C. P., Schnitker, J., Wahn, U., Niggemann, B.

“…Background:  Especially in childhood, sublingual immunotherapy (SLIT) could offer advantages over subcutaneous therapy. However, limited data on its efficacy…”
Get full text

Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency by Rensing-Ehl, A, Warnatz, K, Fuchs, S, Schlesier, M, Salzer, U, Draeger, R, Bondzio, I, Joos, Y, Janda, A, Gomes, M, Abinun, M, Hambleton, S, Cant, A, Shackley, F, Flood, T, Waruiru, C, Beutel, K, Siepermann, K, Dueckers, G, Niehues, T, Wiesel, T, Schuster, V, Seidel, M.G, Minkov, M, Sirkiä, K, Kopp, M.V, Korhonen, M, Schwarz, K, Ehl, S, Speckmann, C

“…Abstract Autoimmune lymphoproliferative syndrome (ALPS) is mainly caused by defects in the CD95 pathway. Raised CD3+TCRαβ+CD4−CD8− double negative T cells and…”
Get full text

Treatment with rhDNase in patients with cystic fibrosis alters in‐vitro CHIT‐1 activity of isolated leucocytes by Weckmann, M., Schultheiss, C., Hollaender, A., Bobis, I., Rupp, J., Kopp, M.V.

“…Summary Recent data suggest a possible relationship between cystic fibrosis (CF) pharmacotherapy, Aspergillus fumigatus colonization (AC) and/or allergic…”
Get full text

Reduced memory B cells in patients with hyper IgE syndrome by Speckmann, C, Enders, A, Woellner, C, Thiel, D, Rensing-Ehl, A, Schlesier, M, Rohr, J, Jakob, T, Oswald, E, Kopp, M.V, Sanal, O, Litzman, J, Plebani, A, Pietrogrande, M.C, Franco, J.L, Espanol, T, Grimbacher, B, Ehl, S

“…Abstract Dominant-negative mutations in STAT-3 have recently been found in the majority of patients with sporadic or autosomal-dominant hyper IgE syndrome…”
Get full text

Effectiveness of a novel endoscopy training concept by Götzberger, M, Rösch, T, Geisenhof, S, Gülberg, V, Schmitt, W, Niemann, G, Kopp, V M, Faiss, S, Heldwein, W, Fischer, M R

“…Training standards in gastrointestinal endoscopy are poorly defined even though different simulators are increasingly used for skills training. In 2001 a new…”
Get more information

Role of immunmodulators in allergen‐specific immunotherapy by Kopp, M. V.

“…To cite this article: Kopp MV. Role of immunmodulators in allergen‐specific immunotherapy. Allergy 2011; 66: 792–797. Allergen‐specific immunotherapy (SIT) is…”
Get full text

High interleukin-13 production by phytohaemagglutinin- and Der p 1-stimulated cord blood mononuclear cells is associated with the subsequent development of atopic dermatitis at the age of 3 years by Lange, J., Ngoumou, G., Berkenheide, S., Moseler, M., Mattes, J., Kuehr, J., Kopp, M. V.

“…Summary Objective The aim of our study was to conduct a prospective investigation into the potential association of cord blood proliferative response and…”
Get full text

Sulphidoleukotriene release of cord blood basophils in response to allergen stimulation correlates with neither a family history of atopy nor a subsequent development of atopic eczema by Walaschek, C., Heinzmann, A., Weckmann, M., Kopp, M. V.

“…Summary Objective We tested a possible relationship between sulphidoleukotriene (SLT) release of cord blood (CB) basophils, a family history of atopy (HA) and…”
Get full text

Allergen-specific T cell reactivity in cord blood: the influence of maternal cytokine production by Kopp, M. V., Zehle, C., Pichler, J., Szépfalusi, Z., Moseler, M., Deichmann, K., Forster, J., Kuehr, J.

“…Background Successful pregnancy is dependent upon T helper (Th)2‐type‐dominated immunological responsiveness in gestation‐associated compartments. Objective In…”
Get full text

Fulvestrant in the treatment of luminal metastatic breast cancer: the balance of effectiveness and safety by Koroleva, I. A., Kopp, M. V.

“…The review presents the results of studies of fulvestrant in metastatic breast cancer (MBC). Hormone therapy is an effective method of treating…”
Get full text

Cytokine levels in children and adults with wheezing and asthma show specific patterns of variability over time by Weckmann, M., Thiele, D., Liboschik, L., Bahmer, T., Pech, M., Dittrich, A.‐M., Fuchs, O., Happle, C., Schaub, B., Ricklefs, I., Rabe, K. F., Mutius, E., Hansen, G., König, I. R., Kopp, M. V., Roesler, B., Welchering, N., Kohistani‐Greif, N., Landgraf‐Rauf, K., Laubhahn, K., Schaub, B., Ege, M., Liebl, C., Mutius, E., Kurz, Johanna, Fuchs, Oliver, Ricklefs, Isabell, Diekmann, Gesa, Sultansei, L., Weckmann, M., Nissen, G., Kopp, M. V., Liboschik, L., Bovermann, X., Steinmetz, A., Voigt, G., Husstedt, B., Nitsche, C., König, I. R., Thiele, D., Brinkmann, F., Dittrich, A.‐M., Happle, C., Malik, A., Schwerk, N., Dopfer, C., Price, M., Grychtol, R., Hansen, G., Zemlin, M., Müller, M., Rietschel, E., Koningsbruggen‐Rietschel, S., Bahmer, T., Kirsten, A.‐M., Pedersen, F., Watz, H., Waschki, B., Rabe, K. F., Herzmann, C., Opitz, A., Gaede, K. I, Zabel, P.

“…Cytokines as biomarkers for asthma underly seasonal variability, as investigated in the large German cohort ALLIANCE. We propose two methods to account for the…”
Get full text

Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature by Vougioukas, V I, Berlis, A, Kopp, M V, Korinthenberg, R, Spreer, J, van Velthoven, V

“…This paper reports the case of a 14-year-old child with Maroteaux-Lamy syndrome (mucopolysaccharidosis type 6) who was treated consecutively for compressive…”
Get more information

The revised guideline on Primary Allergy Prevention by Kopp, M V

“…The recommendations of the revised guideline Primary Allergy Prevention published in 2009 are summarized and discussed. The updated guidelines do not further…”
Get full text

THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF EARLY-STAGE HORMONE-SENSITIVE BREAST CANCER by Koroleva, I. A., Kopp, M. V.

“…Ovarian suppression (OS) is an effective method of treating hormone sensitive breast cancer. The combination of OS and tamoxifen in breast cancer is more…”
Get full text

Effects of ambient ozone on lung function in children over a two-summer period by Kopp, MV, Bohnet, W, Frischer, T, Ulmer, C, Studnicka, M, Ihorst, G, Gardner, C, Forster, J, Urbanek, R, Kuehr, J

“…There is a general consensus that short term exposure to ozone (O3) causes a decrease in lung function parameters such as forced vital capacity (FVC) and…”
Get full text